Nordisk, and into biotech at InterAx — where the next challenge is using functional fingerprints to After running her own academic group in Graz, she spent six and a half years at Novo Nordisk in early Nordisk, putting it in an animal, and watching the effect come back exactly as predicted. After working in the US and at the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief Scientific Officer.

Jacek Mokrosiński "Jacek is a Senior Scientist at Novo Nordisk specializing in molecular pharmacology Since 2021, Jacek has been working at Novo Nordisk at its research sites in the UK (Oxford) and the US

My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed

A pharmacologist by training, she spent more than six years in early R&D at Novo Nordisk before turning

University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck Foundation Fellowship, and Novo Nordisk Foundation Ascending Investigator awards.